메뉴 건너뛰기




Volumn 13, Issue 8, 2011, Pages 1061-1062

Hospitalization: A relevant endpoint in atrial fibrillation management?

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DRONEDARONE; PLACEBO;

EID: 80051733034     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur178     Document Type: Editorial
Times cited : (4)

References (6)
  • 1
    • 70349454206 scopus 로고    scopus 로고
    • Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society severity in atrial fibrillation scale Circ
    • Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society severity in atrial fibrillation scale Circ. Arrhythmia Electrophysiol 2009;2:218-24.
    • (2009) Arrhythmia Electrophysiol , vol.2 , pp. 218-224
    • Dorian, P.1    Guerra, P.G.2    Kerr, C.R.3    O'Donnell, S.S.4    Crystal, E.5    Gillis, A.M.6
  • 3
    • 80051724296 scopus 로고    scopus 로고
    • Impact of Dronedarone on hospitalization burden in patients with atrial fibrillation: Results from the ATHENA study
    • Torp-Pedersen C, Crijns HJGM, Gaudin C, Page RL, Connolly SJ, Hohnloser SH. Impact of Dronedarone on hospitalization burden in patients with atrial fibrillation: Results from the ATHENA study. Europace 2011;13:1118-26.
    • (2011) Europace , vol.13 , pp. 1118-1126
    • Torp-Pedersen, C.1    Crijns, H.J.G.M.2    Gaudin, C.3    Page, R.L.4    Connolly, S.J.5    Hohnloser, S.H.6
  • 4
    • 37549001334 scopus 로고    scopus 로고
    • Rational and design of ATHENA: A placebo controlled, double blind, parallel arm trial to assess the efficacy of Dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter
    • Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Pedersen C. Rational and design of ATHENA: A placebo controlled, double blind, parallel arm trial to assess the efficacy of Dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J Cardiovasc Electrophysiol 2008;19:69-73.
    • (2008) J Cardiovasc Electrophysiol , vol.19 , pp. 69-73
    • Hohnloser, S.H.1    Connolly, S.J.2    Crijns, H.J.3    Page, R.L.4    Seiz, W.5    Torp-Pedersen, C.6
  • 6
    • 77952604921 scopus 로고    scopus 로고
    • A short term randomised double blind, parallel group study to evaluate the efficacy and safety of Dronedarone versus Amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study
    • Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short term randomised double blind, parallel group study to evaluate the efficacy and safety of Dronedarone versus Amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605.
    • (2010) J Cardiovasc Electrophysiol , vol.21 , pp. 597-605
    • Le Heuzey, J.Y.1    De Ferrari, G.M.2    Radzik, D.3    Santini, M.4    Zhu, J.5    Davy, J.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.